The present work aims to examine the worrying problem of antibiotic resistance and the
emergence of multidrug-resistant bacterial strains, which have now become really common …

Clostridium difficile (C. difficile) is a Gram-positive, spore-forming, anaerobic bacillus, which
is widely distributed in the intestinal tract of humans and animals and in the environment. In …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

During the last years probiotics gained the attention of clinicians for their use in the
prevention and treatment of multiple diseases. Probiotics main mechanisms of action …

Background Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides
difficile infection (CDI), but inconsistent effect rates and uncertain evidence levels have …

Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium
difficile infection. Promising findings suggest that FMT may play a role also in the …

Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life
threatening, especially in elderly people and in patients who have dysbiosis of the gut …

Background & Aims Fecal microbiota transplantation (FMT) is recommended for treatment of
recurrent Clostridium difficile infection (rCDI). We performed a single-center randomized trial …

Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been
increasing globally in recent years, particularly as a result of randomised studies in which it …